Study analysis · Neural Plasticity · 2017
Exercise may boost your brain's growth fertilizer—but half the studies found no effect and the evidence quality was low.
In people with MS, Parkinson's, or stroke, regular aerobic exercise was linked to higher levels of BDNF, a protein that helps brain cells adapt, but we don't know the absolute change or whether it improves real-world function.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study combines results from many smaller studies to see if exercise changes a chemical in the brain called BDNF. It found a link that exercise might increase this chemical, but because the original studies were not very strong, we can't say for sure that exercise directly causes the increase.
What’s the bottom line?
Scientists looked at 11 studies of people with multiple sclerosis, Parkinson's disease, or stroke. They wanted to see if aerobic exercise changes BDNF, a protein that helps the brain adapt.
How strong is this study?
The researchers did a good job of searching for studies and combining them, but the studies they found were mostly small and not very well designed. That means we should be cautious about trusting the results too much, even though the overall analysis was done carefully.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
51 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=303)+15.6/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 571 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
This design cannot establish causation — the findings describe an association, not a cause. Mixed primary study designs (including observational and some RCTs) with low methodological quality (PEDro 4.3/10) and small samples; not all included studies were randomized, and meta-analysis pooled only 5 controlled trials, some of which may not be randomized. Thus, causal inference is not warranted.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement was present in the provided text, so potential conflicts cannot be assessed.
The manuscript excerpt lacks a COI/funding declaration and author affiliations, limiting transparency. No specific industry ties or funder involvement can be identified from the provided text.
Key takeaways
- 01
For a program of regular aerobic exercise, the pooled result showed a large standardized effect (SMD 0.84, 95% CI 0.47–1.20) favoring exercise for higher resting BDNF.
- 02
About half of program studies found no significant change.
- 03
Single exercise bouts had mixed results: high-intensity bouts increased BDNF in both studies (moderate effect, r=0.45–0.48), while low-to-moderate bouts increased it in only 1 of 3 studies.
- 04
The study did not report absolute BDNF levels or how many people improved, so we can't say how many extra people benefited.
- 05
The effect is a standardized mean difference, not a relative risk or absolute risk.
- 06
Absolute change was not reported.
Surprising findings
- The pooled effect in neurological populations (SMD 0.84) was larger than the effect reported in healthy adults for a program of exercise (Hedges' g = 0.27).You might expect people with neurological disorders to respond less to exercise, not more. The review suggests a possible greater BDNF response in these populations.
- Single bouts of aerobic exercise had mixed effects, contrary to healthy-adult meta-analyses.In healthy adults, a single session significantly increases BDNF (Hedges' g = 0.46), but in this review only 3 of 5 single-bout studies found an increase.
- About half of the program studies found no significant change in resting BDNF.The meta-analysis showed a large positive effect, yet 5 of 10 individual program studies were null.
- The average methodological quality was low: PEDro 4.3/10.A positive meta-analysis in a high-interest area is built on studies with low quality scores and few blinded assessments.
Practical takeaways
For people with MS, Parkinson's, or stroke, regular aerobic exercise like cycling 3 times per week for ~30 minutes at moderate intensity may support BDNF levels.
The evidence quality is low, absolute BDNF change is unknown, and it is not proven to improve motor function.
low confidenceIf doing single exercise sessions, higher intensity may produce a bigger acute BDNF rise than low-to-moderate intensity.
Only two high-intensity studies were included; safety and individual capacity must come first.
low confidenceConsider accumulating a higher total exercise volume over weeks, since significant studies averaged ~20.6 hours vs ~12.9 hours in null studies.
This is a descriptive comparison, not a proven dose-response; medians were similar (12 h both).
low confidenceDon't treat BDNF as a proven stand-in for brain recovery or motor improvement.
BDNF is linked to plasticity mechanisms, but direct links to improved human motor function are not established.
low confidenceWhy this study matters
The headline effect: large standardized boost in BDNF
Five controlled trials (2 MS, 2 Parkinson's, 1 stroke) showed a large standardized mean difference of 0.84 (95% CI 0.47–1.20, p<0.001) favoring aerobic exercise over usual care/no therapy for resting BDNF. This is a standardized effect, not a relative risk or absolute risk; the absolute BDNF change was not reported.
A 0.84 SMD is conventionally 'large' and is bigger than the small effect seen in healthy adults (Hedges' g = 0.27), suggesting neurological populations might respond more.
Half the program studies found no significant change
Of 10 studies evaluating a program of aerobic exercise, 5 found a significant increase in resting BDNF and 5 found no significant change. Studies with significant increases averaged 20.6 ± 20 hours of exercise, while null studies averaged 12.9 ± 3.9 hours.
It directly undercuts the simple headline that exercise reliably raises BDNF. The response may depend on dose or other factors.
High-intensity single bouts worked; easy ones were inconsistent
Across 5 single-bout studies, 3 found a significant immediate BDNF increase and 2 found no change. Both high/maximal-intensity studies (until exhaustion or symptom-limited maximum) showed increases with moderate correlation effect sizes (r = 0.45–0.48), while only 1 of 3 low-to-moderate intensity studies did.
Intensity may be a key moderator for acute BDNF release, which matters for workout recommendations.
The evidence quality is low
Average PEDro score was 4.3/10. Only 2 of 11 studies had blinded assessment, and no study could blind participants or therapists. Samples averaged 27.5 people, and publication bias is possible.
It's a stark reminder that a meta-analysis can produce a large effect even when the underlying studies are weak.
BDNF is a proxy, not proven function
BDNF is associated with neuroplasticity processes like dendritic growth, neurogenesis, and long-term potentiation. However, the review states that direct links between raised BDNF and improved motor function in humans have not been established.
People often assume higher BDNF automatically means better brain function or recovery, but that's not yet proven in humans.
The studied exercise prescription
Most programs used a bike ergometer 3 times per week for about 30 minutes at 60% VO2max, lasting 3–24 weeks. Participants had MS (6 studies), Parkinson's disease (3), or stroke (2).
It gives a concrete, replicable protocol that viewers can compare with their own routine.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at 11 studies of people with multiple sclerosis, Parkinson's disease, or stroke. They wanted to see if aerobic exercise changes BDNF, a protein that helps the brain adapt.
Research results
For a program of regular aerobic exercise, the pooled result showed a large standardized effect (SMD 0.84, 95% CI 0.47–1.20) favoring exercise for higher resting BDNF. About half of program studies found no significant change. Single exercise bouts had mixed results: high-intensity bouts increased BDNF in both studies (moderate effect, r=0.45–0.48), while low-to-moderate bouts increased it in only 1 of 3 studies.
What this means - more context
The study did not report absolute BDNF levels or how many people improved, so we can't say how many extra people benefited. The effect is a standardized mean difference, not a relative risk or absolute risk. Absolute change was not reported.
To determine the effect of aerobic exercise on brain-derived neurotrophic factor (BDNF) levels in people with neurological disorders.
Systematic review/meta-analysis of 11 studies (303 participants; multiple sclerosis, Parkinson's disease, stroke). A program of aerobic exercise vs usual care/nil therapy showed a large standardized effect on resting BDNF (SMD 0.84, 95% CI 0.47–1.20, p<0.001). Single-bout effects were mixed. Average study quality was low (PEDro 4.3/10). Absolute BDNF change or clinical risk was not reported.
Methods Used
Six electronic databases searched to Dec 2016; 984 articles screened, 11 included (5 RCTs, others controlled/observational). Methodological quality assessed with PEDro. Meta-analysis pooled 5 controlled trials (2 MS, 2 Parkinson's, 1 stroke); 303 participants total, mean age 39–77 years, 55% female, average sample size 27.5.
Main Finding
Aerobic exercise program was associated with higher resting BDNF vs control: large standardized mean difference 0.84 (95% CI 0.47–1.20, p<0.001). About half of program studies (5/10) found no significant change; higher exercise volume (avg 20.6 h) was more likely significant than lower volume (avg 12.9 h). Single bouts were mixed: high-intensity bouts increased BDNF in both studies (moderate effect, r=0.45–0.48), while low-to-moderate bouts increased it in only 1 of 3. Absolute risk/BDNF difference was not reported.
Confidence Level
Low: average PEDro 4.3/10, only 2/11 studies had blinded assessment, participants/therapists could not be blinded, small samples, heterogeneous populations, possible publication bias. No retraction or corrections noted (Crossref/PubMed).
Study Flags
Red Flags
- •Low methodological quality (average PEDro 4.3/10)
- •Only 2 of 11 studies had blinded assessment; participants/therapists could not be blinded
- •Small sample sizes (average 27.5) and possible publication bias
Surprising Findings
The pooled effect in neurological populations (SMD 0.84) was larger than the effect reported in healthy adults for a program of exercise (Hedges' g = 0.27).
You might expect people with neurological disorders to respond less to exercise, not more. The review suggests a possible greater BDNF response in these populations.
Practical Takeaways
For people with MS, Parkinson's, or stroke, regular aerobic exercise like cycling 3 times per week for ~30 minutes at moderate intensity may support BDNF levels.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 571 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
Human Meta-Analysis
Subject
High probability
on the GRADE evidence scale
This study combines results from many smaller studies to see if exercise changes a chemical in the brain called BDNF. It found a link that exercise might increase this chemical, but because the original studies were not very strong, we can't say for sure that exercise directly causes the increase.
Strengths
- Comprehensive search of six databases and reference lists.
- PRISMA and PROSPERO registration.
- Independent screening, data extraction, and quality assessment.
Weaknesses
- Included studies had low methodological quality (average PEDro 4.3/10).
- Only 5 of 11 studies were RCTs; others were observational or controlled trials without randomization.
- Small sample sizes (average 27.5 participants).
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at 11 studies of people with multiple sclerosis, Parkinson's disease, or stroke. They wanted to see if aerobic exercise changes BDNF, a protein that helps the brain adapt.
Research results
For a program of regular aerobic exercise, the pooled result showed a large standardized effect (SMD 0.84, 95% CI 0.47–1.20) favoring exercise for higher resting BDNF. About half of program studies found no significant change. Single exercise bouts had mixed results: high-intensity bouts increased BDNF in both studies (moderate effect, r=0.45–0.48), while low-to-moderate bouts increased it in only 1 of 3 studies.
What this means - more context
The study did not report absolute BDNF levels or how many people improved, so we can't say how many extra people benefited. The effect is a standardized mean difference, not a relative risk or absolute risk. Absolute change was not reported.
To determine the effect of aerobic exercise on brain-derived neurotrophic factor (BDNF) levels in people with neurological disorders.
Systematic review/meta-analysis of 11 studies (303 participants; multiple sclerosis, Parkinson's disease, stroke). A program of aerobic exercise vs usual care/nil therapy showed a large standardized effect on resting BDNF (SMD 0.84, 95% CI 0.47–1.20, p<0.001). Single-bout effects were mixed. Average study quality was low (PEDro 4.3/10). Absolute BDNF change or clinical risk was not reported.
Methods Used
Six electronic databases searched to Dec 2016; 984 articles screened, 11 included (5 RCTs, others controlled/observational). Methodological quality assessed with PEDro. Meta-analysis pooled 5 controlled trials (2 MS, 2 Parkinson's, 1 stroke); 303 participants total, mean age 39–77 years, 55% female, average sample size 27.5.
Main Finding
Aerobic exercise program was associated with higher resting BDNF vs control: large standardized mean difference 0.84 (95% CI 0.47–1.20, p<0.001). About half of program studies (5/10) found no significant change; higher exercise volume (avg 20.6 h) was more likely significant than lower volume (avg 12.9 h). Single bouts were mixed: high-intensity bouts increased BDNF in both studies (moderate effect, r=0.45–0.48), while low-to-moderate bouts increased it in only 1 of 3. Absolute risk/BDNF difference was not reported.
Confidence Level
Low: average PEDro 4.3/10, only 2/11 studies had blinded assessment, participants/therapists could not be blinded, small samples, heterogeneous populations, possible publication bias. No retraction or corrections noted (Crossref/PubMed).
Study Flags
Red Flags
- •Low methodological quality (average PEDro 4.3/10)
- •Only 2 of 11 studies had blinded assessment; participants/therapists could not be blinded
- •Small sample sizes (average 27.5) and possible publication bias
Surprising Findings
The pooled effect in neurological populations (SMD 0.84) was larger than the effect reported in healthy adults for a program of exercise (Hedges' g = 0.27).
You might expect people with neurological disorders to respond less to exercise, not more. The review suggests a possible greater BDNF response in these populations.
Practical Takeaways
For people with MS, Parkinson's, or stroke, regular aerobic exercise like cycling 3 times per week for ~30 minutes at moderate intensity may support BDNF levels.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 571 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
Human Meta-Analysis
Subject
High probability
on the GRADE evidence scale
This study combines results from many smaller studies to see if exercise changes a chemical in the brain called BDNF. It found a link that exercise might increase this chemical, but because the original studies were not very strong, we can't say for sure that exercise directly causes the increase.
Strengths
- Comprehensive search of six databases and reference lists.
- PRISMA and PROSPERO registration.
- Independent screening, data extraction, and quality assessment.
Weaknesses
- Included studies had low methodological quality (average PEDro 4.3/10).
- Only 5 of 11 studies were RCTs; others were observational or controlled trials without randomization.
- Small sample sizes (average 27.5 participants).
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The researchers did a good job of searching for studies and combining them, but the studies they found were mostly small and not very well designed. That means we should be cautious about trusting the results too much, even though the overall analysis was done carefully.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
51 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=303)+15.6/20
- Follow-up+10/10
100 / 100
100 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 571 / 100
Probability of being correct
Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.
This design cannot establish causation — the findings describe an association, not a cause. Mixed primary study designs (including observational and some RCTs) with low methodological quality (PEDro 4.3/10) and small samples; not all included studies were randomized, and meta-analysis pooled only 5 controlled trials, some of which may not be randomized. Thus, causal inference is not warranted.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding statement was present in the provided text, so potential conflicts cannot be assessed.
The manuscript excerpt lacks a COI/funding declaration and author affiliations, limiting transparency. No specific industry ties or funder involvement can be identified from the provided text.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
3 researchersIf this is your work, this is how we attribute it on Fit Body Science. Christopher P. Mackay is listed as the lead author.
- Christopher P. MackayLeadCorresponding